Antineoplastic preparation "Sehydrin": instructions for use
The medicine "Sehydrin" refers to the groupantitumor drugs that effectively inhibit the growth of neoplasms. This tool is based on inhibition of MAO, increase in albumin and glucose tolerance, and integrative effects on a number of biochemical processes. The reception of the preparation "Sehydrin" (instruction confirms) contributes to the cessation of energy losses, provides the reverse development of the processes of weight loss and body exhaustion due to tumor growth, and also allows to reduce the permeability of biomembranes and cell membranes due to the slowing down of the metabolism of xenobiotics. At the same time, this medicine has no mielodepressivnogo action and for a relatively short time eliminates a sense of weakness, pain, fever and such phenomena of respiratory failure as cough and shortness of breath.
An increase in motor activity and an improvement in appetite also provides an antitumor drug "Sehydrin", the price for which is on average 1200-1400 rubles.
Currently, this medicine is being producedexclusively in the form of tablets of red-brown color. Each pellet contains about sixty milligrams of hydrazine sulphate as the main active ingredient. Auxiliary components are polyvinylpyrrolidone, polyethylene glycol 600, highly dispersed silica, disubstituted calcium phosphate, polymethacrylate, magnesium stearate, red iron oxide, dimethicone, titanium dioxide and talc.
Take the drug "Sehydrin" instruction forapplication advises for the treatment of patients with inoperable progressive disseminated and locally advanced forms of malignant neoplasms, with metastases of malignant tumors or relapses. For example, this drug is prescribed for neuroblastoma, lymphosarcoma, astrocytoma, glioblastoma and other brain tumors, lung cancer, larynx, cervix or endometrium, as well as for lymphogranulomatosis, tumors in the mammary glands. When desmoid soft tissue also shows the use of the drug "Sehydrin." The instruction recommends using it and people with fibrosarcoma.
Assign this antitumor agentis strictly prohibited in the case of individual patient intolerance to hydrazine sulphate or if he has an allergic reaction to any additional substances contained in the formulation. With extreme caution, experts advise taking this drug for people with severe impairment of kidney or liver function. In addition, during the period of therapy is contraindicated the use of any type of alcohol by the patient. Also, do not combine this drug with barbiturates to avoid a sharp increase in toxicity. During pregnancy, it is likewise not recommended to take Sehydrin tablets. The instruction does not advise to use them during the lactation period.